186 related articles for article (PubMed ID: 36380134)
1. Acute and chronic inflammation alter immunometabolism in a cutaneous delayed-type hypersensitivity reaction (DTHR) mouse model.
Zizmare L; Mehling R; Gonzalez-Menendez I; Lonati C; Quintanilla-Martinez L; Pichler BJ; Kneilling M; Trautwein C
Commun Biol; 2022 Nov; 5(1):1250. PubMed ID: 36380134
[TBL] [Abstract][Full Text] [Related]
2. Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions.
Schwenck J; Maurer A; Fehrenbacher B; Mehling R; Knopf P; Mucha N; Haupt D; Fuchs K; Griessinger CM; Bukala D; Holstein J; Schaller M; Menendez IG; Ghoreschi K; Quintanilla-Martinez L; Gütschow M; Laufer S; Reinheckel T; Röcken M; Kalbacher H; Pichler BJ; Kneilling M
Theranostics; 2019; 9(13):3903-3917. PubMed ID: 31281521
[TBL] [Abstract][Full Text] [Related]
3. Temporal Dynamics of Reactive Oxygen and Nitrogen Species and NF-κB Activation During Acute and Chronic T Cell-Driven Inflammation.
Schwenck J; Mehling R; Thaiss WM; Kramer D; Menendez IG; Öz HH; Hartl D; Schulze-Osthoff K; Hailfinger S; Ghoreschi K; Quintanilla-Martinez L; Carlsen H; Röcken M; Pichler BJ; Kneilling M
Mol Imaging Biol; 2020 Jun; 22(3):504-514. PubMed ID: 31482411
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory role of reactive oxygen species and nitrogen species during T cell-driven neutrophil-enriched acute and chronic cutaneous delayed-type hypersensitivity reactions.
Mehling R; Schwenck J; Lemberg C; Trautwein C; Zizmare L; Kramer D; Müller A; Fehrenbacher B; Gonzalez-Menendez I; Quintanilla-Martinez L; Schröder K; Brandes RP; Schaller M; Ruf W; Eichner M; Ghoreschi K; Röcken M; Pichler BJ; Kneilling M
Theranostics; 2021; 11(2):470-490. PubMed ID: 33391487
[No Abstract] [Full Text] [Related]
5. Imaging of delayed-type hypersensitivity reaction by PET and 18F-galacto-RGD.
Pichler BJ; Kneilling M; Haubner R; Braumüller H; Schwaiger M; Röcken M; Weber WA
J Nucl Med; 2005 Jan; 46(1):184-9. PubMed ID: 15632051
[TBL] [Abstract][Full Text] [Related]
6. [Effect of a delayed type hypersensitivity reaction on the cytotoxic activity of macrophages, natural and antibody-dependent killer cells].
Gordienko SM
Eksp Onkol; 1987; 9(1):30-4. PubMed ID: 3816657
[TBL] [Abstract][Full Text] [Related]
7. Acanthus montanus: an experimental evaluation of the antimicrobial, anti-inflammatory and immunological properties of a traditional remedy for furuncles.
Okoli CO; Akah PA; Onuoha NJ; Okoye TC; Nwoye AC; Nworu CS
BMC Complement Altern Med; 2008 Jun; 8():27. PubMed ID: 18538006
[TBL] [Abstract][Full Text] [Related]
8. 64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET.
Griessinger CM; Maurer A; Kesenheimer C; Kehlbach R; Reischl G; Ehrlichmann W; Bukala D; Harant M; Cay F; Brück J; Nordin R; Kohlhofer U; Rammensee HG; Quintanilla-Martinez L; Schaller M; Röcken M; Pichler BJ; Kneilling M
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1161-6. PubMed ID: 25587131
[TBL] [Abstract][Full Text] [Related]
9. Reversal of established delayed type hypersensitivity reactions following therapy with IL-4 or antigen-specific Th2 cells.
Biedermann T; Mailhammer R; Mai A; Sander C; Ogilvie A; Brombacher F; Maier K; Levine AD; Röcken M
Eur J Immunol; 2001 May; 31(5):1582-91. PubMed ID: 11465116
[TBL] [Abstract][Full Text] [Related]
10. The combined effect of topical CX-659S, a novel diaminouracil derivative, with topical corticosteroid on the three types of allergic responses in mice or guinea pigs.
Inoue Y; Isobe M; Hayashi H
J Pharmacol Sci; 2003 Jan; 91(1):71-8. PubMed ID: 12686733
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-mediated psoriasis can be suppressed by regulatory T lymphocytes.
Leite Dantas R; Masemann D; Schied T; Bergmeier V; Vogl T; Loser K; Brachvogel B; Varga G; Ludwig S; Wixler V
J Pathol; 2016 Nov; 240(3):366-377. PubMed ID: 27555499
[TBL] [Abstract][Full Text] [Related]
12. The in vitro induction of delayed-type hypersensitivity to allo-antigens of the mouse.
Barrington-Leigh J
J Immunol Methods; 1984 Apr; 69(2):149-63. PubMed ID: 6232322
[TBL] [Abstract][Full Text] [Related]
13. Development of a delayed-type hypersensitivity granuloma model in the mouse for the study of chronic immune-mediated inflammatory disease.
Dunn CJ; Gibbons AJ; Miller SK
Agents Actions; 1989 Jun; 27(3-4):365-8. PubMed ID: 2801325
[TBL] [Abstract][Full Text] [Related]
14. Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia.
Kunstfeld R; Hirakawa S; Hong YK; Schacht V; Lange-Asschenfeldt B; Velasco P; Lin C; Fiebiger E; Wei X; Wu Y; Hicklin D; Bohlen P; Detmar M
Blood; 2004 Aug; 104(4):1048-57. PubMed ID: 15100155
[TBL] [Abstract][Full Text] [Related]
15. Dimeric translationally controlled tumor protein-binding peptide 2 attenuates imiquimod-induced psoriatic inflammation through induction of regulatory T cells.
Cho H; Je JH; Kang J; Jeong MG; Song J; Jeon Y; Lee K; Hwang ES
Biomed Pharmacother; 2022 Aug; 152():113245. PubMed ID: 35689858
[TBL] [Abstract][Full Text] [Related]
16. Cellular players and role of selectin ligands in leukocyte recruitment in a T-cell-initiated delayed-type hypersensitivity reaction.
Doebis C; Siegmund K; Loddenkemper C; Lowe JB; Issekutz AC; Hamann A; Huehn J; Syrbe U
Am J Pathol; 2008 Oct; 173(4):1067-76. PubMed ID: 18755847
[TBL] [Abstract][Full Text] [Related]
17. [Analysis and differentiation of cytergic immune reactions: tuberculine type and cutaneous basophilic hypersensitivity (author's transl)].
Günther O
Immun Infekt; 1975 Jul; 3(3):93-9. PubMed ID: 1081069
[TBL] [Abstract][Full Text] [Related]
18. Depletion of regulatory T cells in a hapten-induced inflammation model results in prolonged and increased inflammation driven by T cells.
Christensen AD; Skov S; Kvist PH; Haase C
Clin Exp Immunol; 2015 Mar; 179(3):485-99. PubMed ID: 25302741
[TBL] [Abstract][Full Text] [Related]
19. Co-activation of macrophages and T cells contribute to chronic GVHD in human IL-6 transgenic humanised mouse model.
Ono R; Watanabe T; Kawakami E; Iwasaki M; Tomizawa-Murasawa M; Matsuda M; Najima Y; Takagi S; Fujiki S; Sato R; Mochizuki Y; Yoshida H; Sato K; Yabe H; Kato S; Saito Y; Taniguchi S; Shultz LD; Ohara O; Amagai M; Koseki H; Ishikawa F
EBioMedicine; 2019 Mar; 41():584-596. PubMed ID: 30772305
[TBL] [Abstract][Full Text] [Related]
20. Noncytotoxic Inhibition of the Immunoproteasome Regulates Human Immune Cells In Vitro and Suppresses Cutaneous Inflammation in the Mouse.
Ah Kioon MD; Pierides M; Pannellini T; Lin G; Nathan CF; Barrat FJ
J Immunol; 2021 Apr; 206(7):1631-1641. PubMed ID: 33674446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
